Patents by Inventor Ilan Volovitz

Ilan Volovitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYTOMETRIC ASSAYS
    Publication number: 20230065632
    Abstract: Provided relates to the field of cytometry, specifically to flow cytometric methods and kits for improved diagnosis, prognosis and monitoring of tumors and other lesions involving immune cell infiltration. Further provided are embodiments of the subject matter which relate to compositions and methods providing high resolution quantitative means for immunophenotyping and immune modeling, and for identification of disease prognostic and therapy predictive biomarkers.
    Type: Application
    Filed: October 24, 2022
    Publication date: March 2, 2023
    Inventors: Ilan VOLOVITZ, Merav LUSTGARTEN, Zvi RAM, Netanel Yakov SHAPIRA, Idan BEN HORIN, Gil DIAMANT
  • Cytometric assays
    Patent number: 11480571
    Abstract: Provided relates to the field of cytometry, specifically to flow cytometric methods and kits for improved diagnosis, prognosis and monitoring of tumors and other lesions involving immune cell infiltration. Further provided are embodiments of the subject matter which relate to compositions and methods providing high resolution quantitative means for immunophenotyping and immune modeling, and for identification of disease prognostic and therapy predictive biomarkers.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: October 25, 2022
    Assignee: The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Ilan Volovitz, Merav Lustgarten, Zvi Ram, Netanel Yakov Shapira, Idan Ben Horin, Gil Diamant
  • IMPROVED CYTOMETRIC ASSAYS
    Publication number: 20180356420
    Abstract: Provided relates to the field of cytometry, specifically to flow cytometric methods and kits for improved diagnosis, prognosis and monitoring of tumors and other lesions involving immune cell infiltration. Further provided are embodiments of the subject matter which relate to compositions and methods providing high resolution quantitative means for immunophenotyping and immune modeling, and for identification of disease prognostic and therapy predictive biomarkers.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 13, 2018
    Applicant: The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Ilan VOLOVITZ, Merav LUSTGARTEN, Zvi RAM, Netanel Yakov SHAPIRA, Idan BEN HORIN, Gil DIAMANT
  • Methods of treating tumors in immune-privileged sites
    Patent number: 8741315
    Abstract: A method of treating cancer in an immune-privileged site of a subject in need thereof is provided. The method comprises systemically administering to an area outside the immune-privileged site of the subject, a therapeutically effective amount of naive, viable cells of a tumor of the subject, the tumor being in the immune-privileged site so as to generate an immune response in the subject, thereby treating the cancer in the immune-privileged site of the subject.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: June 3, 2014
    Assignees: Yeda Research and Development Co. Ltd., The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Ilan Volovitz, Lea Eisenbach, Irun R. Cohen, Zvi Ram, Shimon Slavin
  • METHODS OF TREATING TUMORS IN IMMUNE-PRIVILEGED SITES
    Publication number: 20100189750
    Abstract: A method of treating cancer in an immune-privileged site of a subject in need thereof is provided. The method comprises systemically administering to an area outside the immune-privileged site of the subject, a therapeutically effective amount of naive, viable cells of a tumor of the subject, the tumor being in the immune-privileged site so as to generate an immune response in the subject, thereby treating the cancer in the immune-privileged site of the subject.
    Type: Application
    Filed: September 11, 2008
    Publication date: July 29, 2010
    Applicants: Yeda Research And Development Co. Ltd., The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Ilan Volovitz, Lea Eisenbach, Irun R. Cohen, Zvi Ram, Shimon Slavin